Economy

New obesity drugs
FDA approves Eli Lilly's weight loss pill

Novo Nordisk's competitor Eli Lilly has received approval from the FDA for a GLP-1 pill. The pill should be taken once a day, compared to the weekly injection the pharmaceutical company also offers, for those "seeking convenience," says CEO Dave Ricks.

Analysts estimate that the pill, Foundayo, will reach $14.79 billion in sales by 2030, according to Factset.

Eli Lilly's stock rose about 4 percent on Wednesday. Novo Nordisk, which was the first to come out with a GLP-1 pill, fell sharply on the news and then recovered slightly, although still below zero. 

UK calls for talks on Hormuz coalition

This week, 35 countries will hold talks on forming a coalition with the aim of reopening the Strait of Hormuz. This is stated by British Prime Minister Keir Starmer, writes the FT.

– After this meeting, we will also gather our military strategists to see how we can coordinate our resources, he says, while warning that an international effort could be complex and messy.

Among the measures, Starmer emphasizes that “every conceivable diplomatic path” is preferable.

Musk's space ventures
Sources: Space X one step closer to listing

Elon Musk's space company SpaceX has confidentially filed for an initial public offering, writes Bloomberg, citing sources. The company has now reportedly submitted its draft for a listing to the US Financial Conduct Authority.

If the company is listed on the stock exchange, it is expected to be the largest in the US to date.